|Bid||10.900 x 34700|
|Ask||10.950 x 16400|
|Day's Range||10.900 - 10.950|
|52 Week Range||8.550 - 13.730|
|PE Ratio (TTM)||15.37|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||14.00|
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to SciClone Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SCLN-US. Comparing the performance and risk of SciClone Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of SciClone Pharmaceuticals, Inc.
NEW ORLEANS , June 19, 2017 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale ...